In This Article:
OraSure Technologies (NASDAQ:OSUR) Full Year 2024 Results
Key Financial Results
-
Revenue: US$185.8m (down 54% from FY 2023).
-
Net loss: US$19.5m (down by 136% from US$53.7m profit in FY 2023).
-
US$0.26 loss per share (down from US$0.73 profit in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
OraSure Technologies EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 48%.
Looking ahead, revenue is expected to decline by 7.2% p.a. on average during the next 3 years, while revenues in the Medical Equipment industry in the US are expected to grow by 7.8%.
Performance of the American Medical Equipment industry.
The company's shares are down 22% from a week ago.
Balance Sheet Analysis
While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We've done some analysis and you can see our take on OraSure Technologies' balance sheet.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.